What happened
The FDA granted De Novo authorization to the Teal Wand for home collection and transport of vaginal specimens used with a validated HPV molecular test. The decision established a Class II regulatory pathway for similar devices.
Why it matters
Home collection can remove one barrier to cervical screening, particularly for people who avoid or cannot easily reach an in-clinic pelvic exam. Collection is one step: laboratory processing, results and follow-up remain essential.
What to watch
Insurance coverage, completion of follow-up after positive results, participation among underscreened groups, laboratory logistics and independent real-world outcomes.
